清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Cardiovascular and Mortality Outcomes in Lean Versus Non-lean Steatotic Liver Disease: A Systematic Review and Meta-Analysis

医学 危险系数 内科学 非酒精性脂肪肝 脂肪肝 肝病 疾病 代谢综合征 队列研究 队列 回顾性队列研究 体质指数 荟萃分析 比例危险模型 观察研究 死因 置信区间 不利影响 优势比 相对风险 科克伦图书馆 心理干预 出版偏见 死亡率 梅德林 人口 重症监护医学 瘦体质量 糖尿病 疾病登记处 肝病学 减肥 混淆 脂肪变性 死亡风险
作者
Husam Mohammad Mahmoud Jawarneh,Zi Yong Goh,Mohammad Fayez Alnoimat,Sanad Syam,Hadeel Irshid,Lara Alqadi,Milad R. Falahat,Noorhan Al-Kadhimi,Mohammad Mustafa,Muath A Mustafa,Abdelkader O Rababah,Hala Alrababah,Adel Abdallah
出处
期刊:Cureus [Cureus, Inc.]
卷期号:18 (8): e114731-e114731
标识
DOI:10.7759/cureus.114731
摘要

Steatotic liver disease occurring at a normal body mass index is increasingly recognized, yet whether this phenotype carries a different prognosis from the non-lean phenotype remains contested. We aimed to compare cardiovascular events and mortality between lean and non-lean steatotic liver disease. PubMed, Scopus, and the Cochrane Library were searched from database inception to July 2026. Eligible studies were longitudinal cohorts reporting cardiovascular or mortality outcomes stratified by lean versus non-lean status. Because most contributing cohorts predate the 2023 nomenclature change, studies defined by nonalcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated fatty liver disease (MAFLD) criteria were retained without retrospective reclassification, and this was treated as a source of indirectness. Records were screened and data extracted in duplicate, and risk of bias was appraised using the Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I) with exposure-specific adaptation of its domains. Adjusted time-to-event estimates were preferred, transformed to the logarithmic scale, harmonized to a lean-versus-non-lean direction, and combined using random-effects inverse-variance meta-analysis with the DerSimonian-Laird estimator. Of 395 records identified, 265 were screened, 15 could not be retrieved, and 15 observational cohort studies were included, of which six contributed to at least one pooled analysis. Lean steatotic liver disease was associated with higher all-cause mortality (five studies; pooled hazard ratio (HR), 1.66; 95% CI, 1.48-1.86; P<0.001; I²=63.8%; τ²=0.009), a finding that persisted when restricted to the three studies providing a direct lean-versus-non-lean comparison (HR, 1.64; 95% CI, 1.42-1.90; P<0.001; I²=78.2%; τ²=0.011). Composite cardiovascular outcomes and major adverse cardiovascular events did not differ significantly (five studies; pooled HR/subdistribution hazard ratio (sHR), 0.92; 95% CI, 0.70-1.19; P=0.52; I²=90.7%; τ²=0.077); an HR-only sensitivity analysis excluding the single sHR was similarly null (four studies; HR, 0.96; 95% CI, 0.70-1.30; P=0.77; I²=88.1%; τ²=0.080). Heterogeneity was substantial, and these estimates are inconclusive rather than evidence of equivalence. Cardiovascular mortality was reported by two studies using non-identical effect measures and was not pooled: one study reported an HR of 1.40 (95% CI, 1.12-1.76), and the other reported an sHR of 0.94 (95% CI, 0.47-1.89). No study was rated as having low overall risk of bias; 10 were rated moderate and five serious. Lean steatotic liver disease appears to carry excess all-cause mortality, whereas evidence for cardiovascular event risk and cardiovascular mortality remains insufficient and heterogeneous. Applicability to contemporary MASLD should be interpreted cautiously because included cohorts used heterogeneous disease definitions and body mass index thresholds. The review was prospectively registered.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
7秒前
体贴的小霜完成签到,获得积分10
10秒前
11秒前
精明的彩虹完成签到,获得积分10
13秒前
科研通AI6.4的应助被纯情的阁采纳,获得10
15秒前
科研通AI6.2的应助被纯情的阁采纳,获得10
16秒前
所所的应助被纯情的阁采纳,获得30
16秒前
16秒前
顺心安雁完成签到,获得积分10
20秒前
24秒前
27秒前
桐桐的应助被西红柿采纳,获得10
31秒前
33秒前
Qian完成签到 ,获得积分10
33秒前
动听一德完成签到,获得积分10
39秒前
39秒前
无语的羞花完成签到,获得积分10
40秒前
48秒前
49秒前
纯情的阁发布了新的文献求助10
50秒前
50秒前
纯情的阁发布了新的文献求助30
52秒前
纯情的阁发布了新的文献求助10
56秒前
56秒前
纯情的阁发布了新的文献求助10
58秒前
58秒前
缥缈的鸡翅完成签到,获得积分10
1分钟前
科研通AI6.4的应助被纯情的阁采纳,获得10
1分钟前
1分钟前
故意的冷安完成签到,获得积分10
1分钟前
1分钟前
坚定的咖啡完成签到,获得积分10
1分钟前
冷艳千柳完成签到,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
科研通AI6.4的应助被纯情的阁采纳,获得10
1分钟前
科研通AI6.4的应助被纯情的阁采纳,获得30
1分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
1分钟前
池雨完成签到 ,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158905
求助须知:如何正确求助?哪些是违规求助? 9554522
关于积分的说明 21719373
捐赠科研通 7748459
什么是DOI,文献DOI怎么找? 3427107
关于科研通互助平台的介绍 2552006
邀请新用户注册赠送积分活动 2471370